Clinical trials
Cardiovascular clinical trials
Below are recruiting cardiovascular clinical trials, each written for real people, not researchers. We’re tracking 1,157 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07168421RecruitingPhase 4
Landiolol to prevent fast heart rate during major surgery
This trial tests a short-acting medicine called landiolol to see if it can prevent dangerously fast heart rates during and after major surgery. It is for people who have heart risks and are having a planned non-cardiac surgery.
BernAges 45 years+ - NCT07157774RecruitingPhase 3
Muvalaplin for heart disease in people with high lipoprotein(a)
This study tests a new medicine called muvalaplin that lowers a specific type of cholesterol linked to heart disease. It aims to see if muvalaplin can reduce the risk of future heart attacks, strokes, or related procedures in people with high levels of this cholesterol.
Birmingham, AlabamaAges 18 years+ - NCT06571162Recruiting
Study on LDL cholesterol management for heart disease patients
This study tests whether a clinical pharmacist-led team can help manage LDL cholesterol levels in patients with heart or blood vessel disease. It aims to improve care for people with conditions like coronary artery disease, stroke, or peripheral artery disease.
Salt Lake City, UtahAges 18 years+ - NCT07136675Enrolling by invitation
Healthy Heart & Blood Markers in Chinese Adults
This study aims to create a reference library of healthy hearts and blood markers for Chinese adults. If you qualify, you will help doctors better understand what's normal for people like you.
Beijing, Beijing MunicipalityAges 20–80 - NCT07114718Recruiting
Stent for babies with heart defect needing extra blood flow
This trial tests a special stent for babies with a heart defect that needs a temporary blood vessel to stay open. The stent is placed to help blood flow to the lungs until the baby can have a more permanent surgery.
Los Angeles, CaliforniaAges 1 minute–6 months - NCT07111208Recruiting
Air, noise, and lifestyle effects on heart health
This study tests if wearing a wristband that tracks air and noise can help reduce heart risks in people with early signs of metabolic syndrome. You will also get lifestyle tips to help protect your heart.
Kaunas, Kaunas CountyAges 45–64 - NCT06670677Recruiting
Blood pressure monitoring for early heart risk awareness
This study is testing whether a blood pressure monitoring system called Aktiia can help people become aware of high blood pressure early and predict heart risks. It involves using a smartphone and a wrist bracelet (or just the phone's camera) to take blood pressure readings.
LausanneAges 21–85 - NCT07094087RecruitingPhase 3
Blood clotting medicine for heart surgery bleeding
This trial tests a medicine called 4F-PCC to stop bleeding during complex heart surgery that uses a heart-lung machine. It could help people who have bleeding problems after the surgery.
Los Angeles, CaliforniaAges 18 years+ - NCT07090200Recruiting
Rehabilitation program for COPD with heart or blood vessel disease
This study tests a rehabilitation program for people with COPD who also have heart or blood vessel problems. It aims to help you breathe better and improve your overall health.
Wuhan, HubeiAges 18 years+ - NCT07077304Recruiting
Cardiac imaging study for inflammatory heart diseases
This study uses heart scans (MRI or nuclear imaging) to better understand inflammatory heart conditions. If you have a suspected inflammatory heart disease and are already scheduled for one of these scans, you may be able to join.
ParisAges 18 years+ - NCT06519292Recruiting
Heart side effects from immunotherapy in cancer patients
This trial looks at whether immunotherapy drugs (checkpoint inhibitors) cause heart problems in people with certain cancers. It will help doctors understand who is at risk and how to monitor for side effects.
Amsterdam, North HollandAges 50 years+ - NCT07070635Recruiting
Tea for heart health during menopause
This study tests if drinking 3 cups of English breakfast tea daily for 8 weeks can improve heart health in postmenopausal women who already drink tea. It aims to see if tea offers extra benefits during menopause.
DundeeAges 45–74 - NCT07064473RecruitingPhase 3
Testing vicadrostat plus empagliflozin for diabetes, high blood pressure, and heart disease
This study tests a new pill called vicadrostat taken with another medicine (empagliflozin) to see if it helps people with type 2 diabetes, high blood pressure, and heart disease. It may reduce the risk of heart problems, but you must not have had heart failure or use certain other heart medications.
Anniston, AlabamaAges 18 years+ - NCT07063043Recruiting
A study using a new scan to look at heart disease
This trial is testing a new imaging method (68Ga-FAPI PET/CMR) to better see and understand heart problems. It might help doctors diagnose or monitor conditions like heart failure or inflammation.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06906081RecruitingPhase 2
Finerenone for diabetic nerve damage (FibroCAN study)
This trial tests if finerenone can help people with type 2 diabetes who have early signs of nerve damage affecting their heart and blood vessels (cardiovascular autonomic neuropathy). It aims to see if the drug can improve heart rate control and reduce symptoms.
GistrupAges 40 years+ - NCT07048158Recruiting
A drink for heart health
This study tests a drink called 'Perfect Heartio' to see if it supports cardiovascular health in healthy adults. It may help improve heart function or reduce risk factors.
Cheras, Kuala LumpurAges 18 years+ - NCT07052799RecruitingPhase 3
Should you pause aspirin before a colonoscopy?
This trial compares stopping aspirin versus continuing it before a colonoscopy in people who take aspirin to prevent heart problems. The goal is to find out which approach is safer and works best.
Hong KongAges 18 years+ - NCT07035795Recruiting
Heart and body signal recording study
This study records heart and other body signals from people with medical conditions. It aims to better understand how these signals relate to health.
Hong KongAges 18 years+ - NCT07034352Recruiting
Health impact 360: improving heart health in community settings
This trial tests a community program to improve physical, social, and mental health to prevent heart disease. It may be a good fit if you can join group activities and speak English or Spanish.
Detroit, MichiganAges 18 years+ - NCT07019506Recruiting
Exercise for heart health in cardiovascular disease patients
This trial tests whether a program of 20 physical exercise sessions can improve your aerobic capacity (how well your body uses oxygen during activity). If you have been diagnosed with heart or blood vessel disease and are a patient at Clínica el Rosario, this study may help you understand how exercise can benefit you.
MedellínAges 35–90 - NCT06992284Enrolling by invitation
Heart disease study in Niigata
This study looks at the long-term outlook for people with heart disease in Niigata, Japan. It helps doctors learn more about what affects recovery and health over time.
Niigata, NiigataAges 18 years+ - NCT05775484Recruiting
Exercise program to slow heart and blood vessel aging
This trial tests whether a structured exercise program can slow how quickly your cardiovascular system (heart and blood vessels) “ages” over time. If you’re able to move around outdoors safely, exercise may be a key part of the study.
Singapore, SingaporeAges 21–100 - NCT06981247Recruiting
Heart disease prevention for office workers
This study tests ways to help city bank employees in Karachi lower their risk of heart disease and stroke. It focuses on people who sit a lot at work and want to prevent heart problems.
Karachi, SindhAges 20–65 - NCT05642858Recruiting
Learn heart health tips for people living with HIV
This study tests a text-message education program to help people living with HIV manage cardiovascular (heart and blood vessel) health. It may be helpful if you are 40 or older and can use a smartphone to receive messages.
San Francisco, CaliforniaAges 40 years+
Hear when a new Cardiovascular trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiovascular?
- Yes. Clin2 currently lists 1,157 recruiting cardiovascular studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiovascular trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiovascular trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.